Development of commensal gut microbes-derived non-immunogenic therapeutic leads through identification and evaluation of intestinal targets against chronic metabolic disease. TIET seed grant (PI) 2020-2023.
Development of Nano-bio-composites as next generation arsenal against biofilms. TIET- Virginia Tech Center of Excellence for Emerging Materials (co-PI) 2020-2023.
Gut microbiome-resistant chitosan-EGCG nanoconjugates for efficient intracellular redox homeostasis and maintenance of global metabolome. Bio-X initiative under TIET- Virginia Tech Center of Excellence for Emerging Materials (PI) 2021-2024.
Development of an in vitro pseudo-facilitation model of lipotoxicity in NAFLD-associated metainflammation coupled with characterization of hepatocellular global metabolomic signatures (PI). SERB-SRG 2021-2023.
Identification of immunogenic peptide for diagnosis of orthohantavirus infection. DST Indo-Russia (co-PI) 2022-2025.
Effect of SCFA producing commensals isolated from healthy donors on the mucosal translocation of gut pathobionts. Seed grant from Saudi Arabia (PI) 20220-2023.
Development of gut microbiota-resistant mucoadhesive bio-nano-encapsulation for efficient delivery of epigallocatechin gallate isolated from endophytic fungi of Camelia sinensis (tea). SERB-POWER grant (co-PI) 2022-2025.
An Artificial Colon Model for Microbiota Research (AMMR). BIRAC (PI) 2022-2024
